BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27105909)

  • 81. Degradation of serum amyloid A by isolated perfused rat liver.
    Bausserman LL; Saritelli AL; Van Zuiden P; Gollaher CJ; Herbert PN
    J Biol Chem; 1987 Feb; 262(4):1583-9. PubMed ID: 3543006
    [TBL] [Abstract][Full Text] [Related]  

  • 82. High-Density Lipoproteins and Serum Amyloid A (SAA).
    Webb NR
    Curr Atheroscler Rep; 2021 Jan; 23(2):7. PubMed ID: 33447953
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Serum amyloid A apolipoprotein (apo SAA). Implications in inflammation and in lipoprotein modifications].
    Saile R; Fruchart JC
    Ann Biol Clin (Paris); 1990; 48(2):77-85. PubMed ID: 2188533
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Serum Amyloid A (SAA) Proteins.
    Sack GH
    Subcell Biochem; 2020; 94():421-436. PubMed ID: 32189310
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Changes in serum amyloid A, plasma high-density lipoprotein cholesterol and apolipoprotein A-I as useful biomarkers for
    Franco Fontes C; Silva Bidu N; Rodrigues Freitas F; Maranhão RC; Santos Monteiro AS; David Couto R; Martins Netto E
    J Med Microbiol; 2023 Jun; 72(6):. PubMed ID: 37389586
    [No Abstract]   [Full Text] [Related]  

  • 86. Serum amyloid A does not affect high-density lipoprotein cholesterol measurement by a homogeneous assay.
    Sato M; Ohkawa R; Low H; Nishimori M; Okubo S; Yoshimoto A; Yano K; Kameda T; Yatomi Y; Tozuka M
    Clin Biochem; 2019 Jan; 63():97-101. PubMed ID: 30342019
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Clinical Value of Serum Amyloid-A Protein, High-density Lipoprotein Cholesterol and Apolipoprotein-A1 in the Diagnosis and Follow-up of Neonatal Sepsis.
    Bourika V; Hantzi E; Michos A; Margeli A; Papassotiriou I; Siahanidou T
    Pediatr Infect Dis J; 2020 Aug; 39(8):749-755. PubMed ID: 32251257
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Apolipoprotein A1 Forms 5/5 and 5/4 Antiparallel Dimers in Human High-density Lipoprotein.
    He Y; Song HD; Anantharamaiah GM; Palgunachari MN; Bornfeldt KE; Segrest JP; Heinecke JW
    Mol Cell Proteomics; 2019 May; 18(5):854-864. PubMed ID: 30659061
    [TBL] [Abstract][Full Text] [Related]  

  • 89. SAA does not induce cytokine production in physiological conditions.
    Kim MH; de Beer MC; Wroblewski JM; Webb NR; de Beer FC
    Cytokine; 2013 Feb; 61(2):506-12. PubMed ID: 23165195
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Heterogeneity of human serum amyloid A proteins.
    Bausserman LL; Herbert PN; McAdam KP
    J Exp Med; 1980 Sep; 152(3):641-56. PubMed ID: 6774048
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Binding of human serum amyloid A (hSAA) and its high-density lipoprotein3 complex (hSAA-HDL3) to human neutrophils. Possible implication to the function of a protein of an unknown physiological role.
    Preciado-Patt L; Pras M; Fridkin M
    Int J Pept Protein Res; 1996 Dec; 48(6):503-13. PubMed ID: 8985783
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Human high-density lipoprotein associated amyloid A protein. Structural characteristics, relation to apo A-I and A-II concentrations, and plasma clearance kinetics in the rat.
    Ehnholm C; Teppo AM; Ohisalo JJ; Maury CP
    Scand J Rheumatol; 1985; 14(2):201-8. PubMed ID: 3923617
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Asthmatic patients with high serum amyloid A have proinflammatory HDL: Implications for augmented systemic and airway inflammation.
    Yao X; Kaler M; Qu X; Kalidhindi RSR; Sviridov D; Dasseux A; Barr E; Keeran K; Jeffries KR; Yu ZX; Gao M; Gordon S; Barochia AV; Mills J; Shahid S; Weir NA; Kalchiem-Dekel O; Theard P; Playford MP; Stylianou M; Fitzgerald W; Remaley AT; Levine SJ
    J Allergy Clin Immunol; 2024 Apr; 153(4):1010-1024.e14. PubMed ID: 38092139
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Immune functions of serum amyloid A.
    Eklund KK; Niemi K; Kovanen PT
    Crit Rev Immunol; 2012; 32(4):335-48. PubMed ID: 23237509
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Lipid clearance and amyloid formation by serum amyloid A: exploring the links between beneficial and pathologic actions of an enigmatic protein.
    Jayaraman S; Urdaneta A; Bullitt E; Fändrich M; Gursky O
    J Lipid Res; 2023 Sep; 64(9):100429. PubMed ID: 37604227
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Amyloid protein SAA is an apoprotein of mouse plasma high density lipoprotein.
    Benditt EP; Eriksen N; Hanson RH
    Proc Natl Acad Sci U S A; 1979 Aug; 76(8):4092-6. PubMed ID: 226994
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Serum amyloid A (SAA), a protein without a function: some suggestions with reference to cholesterol metabolism.
    Kisilevsky R
    Med Hypotheses; 1991 Aug; 35(4):337-41. PubMed ID: 1943886
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Evidence for qualitative abnormalities in high-density lipoproteins from myeloma patients: the presence of amyloid A protein could explain HDL modifications.
    Hachem H; Favre G; Soula G
    Biochim Biophys Acta; 1988 Nov; 963(2):271-7. PubMed ID: 3196732
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Degradation of serum amyloid A and apolipoproteins by serum proteases.
    Bausserman LL; Herbert PN
    Biochemistry; 1984 May; 23(10):2241-5. PubMed ID: 6428449
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Trauma, high density lipoproteins, and serum amyloid protein A.
    Eriksen N; Benditt EP
    Clin Chim Acta; 1984 Jul; 140(2):139-49. PubMed ID: 6432369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.